YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSAH6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,259
Award facts
- Contract value 100% obligated
- $1,259.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) one-dose vials on December 17, 2025, with an ultimate completion date of January 9, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a routine procurement action for vaccine products supporting Department of Defense medical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR, which was awarded on November 13, 2025, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC carries a $499,999,999 ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract structure enables the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical products, including vaccines, prescription medications, biologics, and medical consumables to support military healthcare facilities worldwide, with DMS Pharmaceutical Group demonstrating consistent performance across diverse pharmaceutical categories.
Quick answers
Who was awarded contract SPE2DR26FSAH6?
SPE2DR26FSAH6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FSAH6 worth?
The government has obligated $1,259 on SPE2DR26FSAH6.
Is contract SPE2DR26FSAH6 an order under another contract?
Yes. SPE2DR26FSAH6 is a delivery order under SPE2DR25D9332, an indefinite delivery contract.
Was contract SPE2DR26FSAH6 competed?
The extent of competition for SPE2DR26FSAH6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award